A clinical study of haridradi avaleha in the management of tamaka shwasa with special reference to childhood bronchial asthma
试验速览
- 阶段
- 1/2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- frequency of shwasa vegas, wheezing, kapha, night symptoms, relief in sitting posture etc symptoms will be reliefed
研究概览
简要总结
- Bronchial asthma,the commonest chronic respiratory disease in childhood,is characterised by reccurent paroxymal wheeze and respiratory distress.Although asthma can occur in people of any age,infants,most
children with the illness developed it by about the age of (5-16)years.
2.Children with lower immunity become more susceptible to lower respiratory disorder.It is one of the most common chronic disease among children causing substantial morbidity.
- The current management of tamaka shwasa(childhood bronchial asthma) by modern medicine is only providing short term symptomatic relief but does not provide any long term relief to the patient. In the
present scenario Ayurveda has many drugs which are safe and effective in the treatment of Tamaka shwasa and also useful to prevent the recurrence of attacks and promoting the growth of children at the same time.
4.Therefore Ayurveda herbal combination Haridradi avaleha mentioned in Gadanigraha Hikkashwasadhikar is taken as trial drug in this study.
研究设计
- 研究类型
- Interventional
- 分配方式
- Computer generated randomization
- 盲法
- Participant Blinded
入排标准
- 年龄范围
- 5.00 Year(s) 至 16.00 Year(s)（—）
- 性别
- All
入选标准
- •1 subject with age group 5 to 16 Years will be included in the study irrespective of sex , Caste & religion.
- •PEFR>60% of personal best Intermittent, Mild persistent, Moderate persistent cases of childhood bronchial asthma.
排除标准
- •Age below 5 and more than 16 Years.
- •PEFR<60% of personal best.
- •Severe persistent cases of asthma.
- •Patients taking oral or inhaled steriods on regular basis.
结局指标
主要结局
frequency of shwasa vegas, wheezing, kapha, night symptoms, relief in sitting posture etc symptoms will be reliefed
时间窗: 15thday, 30th day, 45th day, 60th day
次要结局
- Not applicable(Not applicable)